Hydrocodone Bitartrate And Acetaminophen
Product Images NDC 67296-0649

3 FDA label images from Redpharm Drug Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydrocodone Bitartrate And Acetaminophen (NDC 67296-0649). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Copy Of Label (6729606491)

Copy Of Label (6729606491)
Label for HYDROCODONE BITARTRATE AND ACETAMINOPHEN 10/500MG tablets. The label indicates 20 tablets in the package, Rx only, with lot number 55D10A1 and expiration date 04/13. It is a Schedule III controlled substance, manufactured for Qualitest Pharmaceuticals and distributed by Redpharm Drug Inc. The label includes storage temperature instructions and a barcode.*
FDA Label Image

Structural Formula (Image1)

Structural Formula (Image1)
Chemical structure diagram displaying the molecular formulas and structure of the active ingredients hydrocone bitartrate and acetaminophen. The image includes molecular formula annotations and molecular weight (M.W. 494.5).*
FDA Label Image

Structural Formula (Image2)

Structural Formula (Image2)
Chemical structure diagram of a compound with molecular formula C8H9NO2 and molecular weight 151.16, showing a benzene ring bonded to a methoxy group (CH3O) and a hydroxyl group (OH), connected to a CONH group. The image is associated with the product HYDROCODONE BITARTRATE AND ACETAMINOPHEN by RedPharm Drug Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.